Insider Transactions in Q4 2020 at Avalo Therapeutics, Inc. (AVTX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2020
|
Garry Arthur Neil CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
3,599
+4.43%
|
$7,198
$2.28 P/Share
|
|
Dec 10
2020
|
Christopher Ryan Sullivan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,095
+38.76%
|
$10,190
$2.28 P/Share
|
|
Dec 10
2020
|
James Archie Harrell Jr Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
171
+0.6%
|
$342
$2.28 P/Share
|
|
Dec 03
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Dec 03
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
20,000
+0.07%
|
$40,000
$2.44 P/Share
|
|
Nov 25
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Nov 25
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
15,000
+0.05%
|
$30,000
$2.39 P/Share
|
|
Nov 24
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Nov 24
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
47,733
+0.16%
|
$95,466
$2.4 P/Share
|
|
Nov 23
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Nov 23
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
37,267
+0.12%
|
$74,534
$2.32 P/Share
|